Abstract

How to Develop and Maintain a Hazardous Drug List

Author(s): Dillon L Rad

Issue: May/Jun 2019 - Volume 23, Number 3

Page(s): 182-186

Download in electronic PDF format for $75
  • How to Develop and Maintain a Hazardous Drug List Page 1
  • How to Develop and Maintain a Hazardous Drug List Page 2
  • How to Develop and Maintain a Hazardous Drug List Page 3
  • How to Develop and Maintain a Hazardous Drug List Page 4
  • How to Develop and Maintain a Hazardous Drug List Page 5

Abstract

United States Pharmacopeia Chapter <800>, concerned with the handling of hazardous drugs in healthcare settings, requires that any entity handling such drugs maintain a hazardous drug list. While this list must include any drug found on the latest NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, entities are expected to include other drugs and substances of concern. This article provides guidance on the creation and maintenance of such a list.

Related Keywords

  • United States Pharmacopeia Chapter <800> Hazardous Drugs - Handling in Healthcare Settings
  • Hazard Communication Standard
  • Occupational Safety and Health Agency
  • OSHA
  • National Institute for Occupational Safety and Health
  • NIOSH
  • List of Antineoplastic and Other Hazardous Drugs
  • workplace safety
  • worker exposure
  • carcinogenicity
  • teratogenicity
  • reproductive toxicity
  • low dose organ toxicity
  • genotoxicity
  • Globally Harmonised System of Classification and Labelling of Chemicals
  • safety data sheets

Related Categories

  • LEGAL
  • SUPPORT
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • ADVERSE DRUG EVENTS
  • HAZARDOUS DRUGS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2019
Pg. 182-186
How to Develop and Maintain a Hazardous Drug List
Author(s): Dillon L Rad
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2021
Pg. 356
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 21-27
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Author(s): Cabaleiro Joe
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Jul/Aug 2020
Pg. 270-276
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2006
Pg. 446-448
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
May/Jun 2017
Pg. 180
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Author(s): Allen Loyd V Jr
Mar/Apr 2007
Pg. 149-151
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 182-190
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Author(s): Mixon Bill, Nain John
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 118-124
Quality Control: (Material) Safety Data Sheets
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 511-518
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Author(s): Hutson Chad, Day A J
Jan/Feb 2009
Pg. 56-62
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Jul/Aug 2009
Pg. 300-310
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
Author(s): McElhiney Linda F
Sep/Oct 2022
Pg. 358-362
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Author(s): Lopez C Vidal, Rios GL Quito